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Abstract
Objective: Chronic gastritis is a histological entity and is primarily 
associated with Helicobacter pylori infection. The main reason for 
controversy is the lack of correlation between dyspeptic symptoms 
and histopathologic changes. The purpose of this study was to com-
pare histological findings with dyspeptic symptoms in adolescents.
Methods: Adolescents aged 10 to 19 years old with dyspeptic 
symptoms were referred to upper endoscopy. A protocol was syste-
matically submitted to all patients prior to endoscopy. Histopatho-
logic examination was performed on biopsy specimens. H. pylori 
infection was detected by rapid urease test and histology. 
Results: A total of 162 consecutive outpatients with dyspeptic com-
plaints and indication for endoscopy were entered in the database 
of this study. The mean age of the sample was 16 years old; There 
were 120 females (74%) and 42 males (26%). Helicobacter pylori 
were present in 123 patients (75.9%) with a Pearson’s coefficient of 
0.7 (infection versus symptoms). The frequency of gastritis in the an-
trum and incisura angularis was significantly higher in subjects who 
had epigastric pain (p=0,004). Superficial gastritis was 2 times more 
frequent among subjects who had epigastric pain than those who 
do not presented (p=0,012). Severe gastritis was significantly more 
frequent among those who had epigastric pain (p=0,016). There 
was no correlation between gastritis and other dyspeptic symptoms.
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Introduction
Gastritis is common disorders that affect dyspeptic 
patients. The definitions of gastritis are based on 
morphological data. It represents a heterogeneous 
group of macroscopic and microscopic changes of 
gastric mucosa resulting from injury of varied ori-
gin, usually associated with an acute or chronic 
inflammatory response. The term gastritis is used 
not only by laymen but also by many physicians as 
synonymous with dyspepsia, and by endoscopists 
to describe macroscopic changes of gastric muco-
sa, with almost no significance as an indicator of 
histologic evidence of gastritis. The main reason 
for controversy is the lack of correlation between 
the clinical and endoscopic and histopathologic 
changes. A wide variety of environmental agents, 
chemicals and infectious, can damage the stomach 
lining, causing a number of diseases, acute and 
chronic, specific and nonspecific, encompassed 
under the title of gastritis [1]. The designation of 
gastritis should be restricted to cases where besi-
des cell damage and regenerative process, there 
is infiltration of inflammatory mucosa, occasionally 
with the presence of lymphoid follicles, especially 
being related to infection by Helicobacter pylori 
(Hp). Histologic examination of gastric mucosal 
biopsies is necessary to establish diagnosis of gas-
tritis. In clinical practice, the role of the pathologist 
who evaluates a gastric biopsy for gastritis is to 
find the cause of gastritis because that will provide 
direct targets toward which therapeutic measures 
can be directed [2].
The chronic gastritis is a histological entity and 
is primarily associated with Helicobacter pylori in-
fection [3, 4]. Chronic gastritis is characterized by a 
chronic inflammatory cell infiltrate located mainly in 
the corium of the gastric mucosa, but sometimes 
also in the submucosa, consisting mainly of lympho-
cytes and plasma cells. The chronic inflammatory 
process affects the stomach and causes progressive 
destruction of glandular structures in some cases 
favoring the development of gastric atrophy [5]. The 
main feature is diffuse and superficial involvement 
of antrum location. The micronodular aspect obser-
ved in the beard of antrum mucosa is quite specific 
but has low sensitivity. The erythema observed in 
the antrum and the presence of erosions are often 
described in chronic gastritis associated with Heli-
cobacter pylori infection, as well as areas of edema, 
subtle changes in mucosal folds and opalescence 
"pearl" of the mucosa.
The infection by Helicobacter pylori is considered 
a risk factor for type I carcinogenesis; also cited as 
the main cause of antral gastritis, is credited as a 
co-environmental factor in gastric carcinogenesis. 
Some more virulent H. pylori strains produce a pro-
tein encoded by the cytotoxin-associated gene (cag 
A). Infection by certain strains associated with this 
cytotoxin present a greater relationship with epithe-
lial cell damage and cytotoxicity, with production 
of IL-8 pro-inflammatory. However, the influence 
of the conditions of the cag A in the development 
of gastric cancer is unclear, but there’s hypothesis 
by this event. The appearance of gastric carcinoma 
is related to the sequential progression of chronic 
Conclusion: This study shows that there is a correlation between 
epigastric pain and superficial gastritis of greater intensity and in-
fection by H. pylori. There is no correlation between epigastric pain 
and intestinal metaplasia in adolescents. Gastritis of the antrum and 
incisura angularis showed a correlation to regurgitation. Gastritis was 
not associated to other dyspeptic symptoms 
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gastritis to atrophic gastritis, intestinal metaplasia 
(IM), dysplasia and finally carcinoma. This sequence 
of gastric carcinogenesis, also called "Correa’s Cas-
cade" was initiated by Helicobacter pylori infection. 
The development of dysplasia from normal muco-
sa is a result of complex phenomena that occur 
through atrophy and metaplasia. The phenomena 
best known are: the loss of DNA repair capacity, 
increased endothelial cell proliferation, free radicals 
of oxygen, and the presence of nitrosamines, nitric 
oxide and bacterial products, including toxins.
Helicobacter pylori infection is associated with an 
increased risk of gastric cancer, although the risk 
is greatest in the subgroup of patients who have 
extensive atrophic gastritis and intestinal metaplasia 
(IM). Helicobacter pylori act as a trigger sequence 
that begins with atrophic gastritis and progresses to 
immature forms of intestinal metaplasia and dyspla-
sia. Preliminary data suggest that eradication of He-
licobacter pylori does not reverse intestinal metapla-
sia and moderate-to-severe atrophy rarely regresses 
[6]. However, it is possible that eradication could 
prevent progression to immature forms of intestinal 
metaplasia and dysplasia. It should be emphasized 
that Hp infection is not the only cause of IM. In 
terms of histological changes IM may represent the 
“point of no return” [7]. 
In general, children experience less inflammation 
than adults. Adolescence is an intermediate pe-
riod between childhood and adulthood. This fact 
generates questions that emphasize the need for 
studying the behavior of gastric inflammation in 
adolescents, which will help in the development of 
treatment strategies.
The aim of this study was to compare histological 
findings with dyspeptic symptoms in adolescents.
Methods
Epidemiological variables and data of upper gas-
trointestinal endoscopies were obtained from pa-
tients in routine clinical practice in a medical cen-
ter in Crato, Ceará, Brazil, over a 6 month period 
(April 2005 to September 2005). The collected data 
were tabulated in an electronic database. The par-
ticipating institution is a community-based hospital, 
serves as a primary care center for its region and 
had endoscopy unit of the open access, so that 
primary care providers can refer their patients di-
rectly without gastroenterological consultation. It is 
also a reference center for digestive disease. This 
prospective data base was not used to investigate 
consecutive adult patients complaining of dyspep-
sia, who were referred for endoscopy
All patients were adolescents aged 10 to 19 
years. The pre-selection of patients was performed 
by general practitioners in primary health care, gui-
ding individuals who had dyspeptic complaints and 
were considered fit for endoscopy. Dyspepsia was 
defined according to the Rome II Consensus criteria 
as “moderate-to-very-severe pain and discomfort 
centered in the upper abdomen lasting for at least 
4 weeks”. In the absence of alarm symptoms and 
chronic intake of nonsteroidal anti-inflammatory 
drugs (NSAIDs), it was defined as “uncomplicated.” 
Dyspepsia subtypes were categorized as reflux-like, 
ulcer-like, dysmotility-like, or unspecified as pre-
viously described.
A questionnaire was systematically submitted to 
all patients prior to endoscopy after signing the in-
formed consent. It included multiple variables such 
as: age, sex, comorbidities and coprescriptions (in-
cluding steroids and anticoagulants), regular NSAIDs 
intake, H. pylori infection, presence of any alarm 
symptoms and type of dyspepsia. The endoscopist 
entered the procedure data, including presenting 
symptoms, preprocedure diagnosis, recent tests, 
and diagnostic findings immediately following en-
doscopy. Critical variables including age, sex, co-
morbidities, procedure indication, and endoscopic 
findings were required fields for all patients. Only 
patients who had dyspepsia as an indication were 
considered. Records of monitoring patients were 
excluded from the study.
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Patients were included if they had dyspeptic 
symptoms; complete diagnostic examination of the 
esophagus, stomach, and duodenum; no proven 
preprocedure upper GI diagnosis; no previous va-
rices treatment, dilation, stenting, tumor ablation, 
or foreign body removal; and no recent endoscopy 
or barium meal. H. pylori infection was detected 
by rapid urease test and histology using standard 
diagnostic techniques, the Silver and Giemsa stains. 
Gastritis was diagnosed in accordance with Sydney 
System modified by Dixon (8).
Analysis of variance was used for the comparison 
of mean values, and the chi-square test with Yates’s 
correction, the Fisher´s test and the odds ratio, 
when appropriate, were used for the comparison 
of proportions. The fifth percentile, i.e., the value 
of alpha error, was chosen as the cut-off point. A 
post-hoc analysis was performed for the calculation 
of statistical error. Linear correlation was performed 
by Pearson's correlation coefficient. 
All components necessary for human research cri-
teria were used and scrutinized by the local Ethics 
Committee.
Results
A total of 162 consecutive outpatients with dyspep-
sia as an indication for upper GI endoscopy were in-
serted in the structured database. The mean age of 
the sample was 16 years old. There were 120 fema-
les (74%) and 42 males (26%). A total of 69 patients 
(42.59%) were on NSAIDs in the past 30 days befo-
re endoscopy. Epigastric pain was the main clinical 
feature. There were 97 patients (59.87%) with mo-
derate to severe epigastric pain for a minimum of 
90 days. Half of the patients had heartburn about 
3 days a week. Regurgitation was present in 49 pa-
tients (30.8%). The great majority had postprandial 
fullness. Half of patients had nausea. Almost none 
had vomiting. There were 9 patients with hemate-
mesis and none with melena and/or hematochezia. 
The main preprocedure diagnosis was gastritis in 
135 patients (83%).
Endoscopic Findings
Gastritis was present in 68 patients (41.9%), 
esophagitis in 27 patients (16,7%), peptic ulcer in 
12 (6,8%), 2 patients had gastric ulcers. Endoscopy 
was considered normal in 74 patients (45,7%). One 
patient had hiatal hernia, another ectopic pancreas 
and another Brunner’s tumor of duodenum. The 
rapid urease test was positive in 58,6% of patients.
Histopathological Findings
Histopathology examination was performed on 
biopsy specimens of all 162 patients undergoing en-
doscopic examination. H. pylori were present in 123 
(75.9%) of cases. Considering the rapid urease test 
and histopathology, the prevalence of H. pylori in 
the study sample was 78%. The diagnosis of gastritis 
was present in 70.9 % of biopsies. In all instances 
the gastritis was in antrum and in 75.6 % of patients 
with histologic gastritis was also found in the body. 
Most individuals (58.2 %) had superficial gastritis, 
and 96.5% of gastritis had mild to moderate inten-
sity. 19 subjects (11.7%) had intestinal metaplasia, 
these 18 subjects were positive for H. pylori (95 %), 
and only 75% of those without intestinal metaplasia 
were also positive for Hp. This difference is very close 
to significance (p = 0.58). 31% had lymphoid follicu-
lar hyperplasia. Of these, 98.2 % were carriers of H. 
pylori, against 67% who had no follicular lymphoid 
hyperplasia. Foveolar hyperplasia was found in 86% 
of biopsies and reactive atypia in 73.0%. It is impor-
tant to report that one subject had mild dysplasia.
Other Findings
The fecal parasitology test was submitted by 135 
patients, and 45 patients (34%) had at least one 
parasite. All of these patients had Ascaris lumbri-
coides; Giardia lamblia and Entamoeba sp. were 
prevalents.
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Histopathological findings confronted 
with clinical elements
The relationship between each digestive sign or 
symptom and presence of gastritis on histopatho-
logy were studied (Table 1-3). The association bet-
ween epigastric pain and gastritis on histopathology 
was analyzed. Regarding location, the frequency of 
gastritis in the antrum and incisura angularis was 
significantly higher in subjects who had epigastric 
pain (p=0,004); regarding the type, superficial gas-
tritis was 2 times more frequent among subjects 
who had epigastric pain than those who do not 
presented (p=0,012) with respect to intensity, gas-
tritis with greater intensity (p=0,016) was signifi-
cantly more frequent among those who had epigas-
tric pain. Regarding intestinal metaplasia (p=0,743) 
and lymphoid follicular hyperplasia (p=0,768) no 
correlation with epigastric pain (Table 1). There was 
Table 1.  Relation between “epigastric pain” and the presence of gastritis on the histopathological exam.
Characteristics of gastritis Total
“epigastric pain”
p-value
Absent (N=27) (%1) Present (N=1350) (%2)
Gastritis
Absent 47 52,0 24,4
0,0044
Present 115 48,0 75,6
Gastritis of the Antrum
Absent 47 52,0 24,4
0,0044
Present 115 48,0 75,6
Gastritis of the Body
Absent 75 52,0 24,4
0,2914
Present 87 55,6 75,6
Gastritis of the Incisura
Absent 53 52,0 24,4
0,0064
Present 109 55,6 75,6
Type of gastritis
Absence of Gastritis 47 52,0 24,4
0,0124Superficial 67 55,6 75,6
Difuse 48 51,9 75,6
Intensity of Gastritis
Absence of Gastritis 47 52,0 24,4
0,0164Mild 51 55,6 75,6
Moderate or severe 64 51,9 75,6
Metaplasia
Absent 143 52,0 24,4
0,7433
Present 19 92,6 75,6
Hiperplasia
Absent 106 52,0 24,4
07684
Present 56 63,0 75,6
1.  Probability to have or no Gastritis, as it doesn’t show  
“epigastric pain”.
2.  Probability to have or no Gastritis, as it  shows  
“epigastric pain”.
3. Fisher’s exact test. 4. X2 test
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no association between heartburn and gastritis on 
histopathology (Table 2). Gastritis of the antrum 
and incisura angularis was present with a frequency 
significantly higher among those with regurgitation 
(Table 3). Gastritis in histopathology showed no as-
sociation with gastric fullness and nausea (table 4 
and 5), neither vomiting nor gastrointestinal blee-
ding (table 6 and 7). Of the 162 patients studied 
with clinical dyspepsia, 123 (75.9%) had H. pylori 
infection; of which 115 (70.9 %) showed histology 
consistent with gastritis. We estimated the proba-
bility that the adolescent is infected with H. pylori, 
since had or no signs of digestive symptoms. The 
likelihood of having H. pylori among those who had 
pain in the stomach was 81%, while those who did 
not have symptom the probability was 63%, and 
Table 2.  Relation between “heartburn” and the presence of gastritis on the histopathological exam. histo-
pathological exam.
Characteristics of gastritis Total
“Heartburn”
p-value
Absent (N=78) (%1) Present (N=84) (%2)
Gastritis
Absent 47 32,0 26,2
0,4114
Present 115 68,0 73,8
Gastritis of the Antrum:
Absent 47 32,0 26,2
0,4114
Present 115 68,0 73,8
Gastritis of the Body
Absent 75 47,4 45,2
0,7794
Present 87 52,6 54,8
Gastritis of the Incisura
Absent 53 37,2 28,6
0,2434
Present 109 62,8 71,4
Type of Gastritis
Absence of Gastritis 47 32,0 26,2
0,3554Superficial 67 43,6 39,3
Difuse 48 24,4 34,5
Intensity of Gastritis
Absence of Gastritis 47 32,1 26,2
0,3014mild 51 34,6 28,6
Moderate or severe 64 33,3 45,2
Metaplasia
Absent 143 91,0 85,7
0,3363
Present 19 9,0 14,3
Hiperplasia
Absent 106 71,8 59,5
0,1014
Present 56 28,2 40,5
1.  Probability to have or no Gastritis, as it doesn’t show  
“heartburn”.
2.  Probability to have or no Gastritis, as it  shows  
“heartburn“.
3. Fisher’s exact test. 4. X2 test.
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Table 3.  Relation between “regurgitation” and the presence of  gastritis on the histopathological exam.
Characteristics of gastritis Total
“Regurgitation”
p-value
Absent (N=112) (%1) Present (N=50) (%2)
Gastritis
Absent 47 34,0 18,0
0,0394
Present 115 66,1 82,0
Gastritis of the Antrum:
Absent 47 34,0 18,0
0,0394
Present 115 66,1 82,0
Gastritis of the Body
Absent 75 50,0 38,0
0,1574
Present 87 50,0 62,0
Gastritis of the Incisura
Absent 53 37,2 22,0
0,0524
Present 109 62,8 78,0
Type of Gastritis
Absence of Gastritis 47 33,9 18,0
0,1114Superficial 67 39,3 46,0
Difuse 48 26,8 36,0
Intensity of Gastritis
Absence of Gastritis 47 33,9 18,0
0,1194mild 51 29,5 36,0
Moderate or severe 64 36,6 46,0
Metaplasia
Absent 143 87,5 90,0
0,6483
Present 19 12,5 10,0
Hiperplasia
Absent 106 68,8 58,0
0,1844
Present 56 31,3 42,0
1.  Probability to have or no Gastritis, as it doesn’t show  
“regurgitation”.
2.  Probability to have or no Gastritis, as it  shows  
“regurgitation”.
3. Fisher’s exact test. 4. X2 test.
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Table 4.  Relation between “postprandial fullness” and the presence of gastritis on the histopathological 
exam.
Characteristics of gastritis Total
“fulness”
p-value
Absent (N=57) (%1) Present (N=105) (%2)
Gastritis
Absent 47 35,1 25,7
0,2094
Present 115 64,9 74,3
Gastritis of the Antrum:
Absent 47 35,1 25,7
0,2094
Present 115 64,9 74,3
Gastritis of the Body
Absent 75 49,1 44,8
0,5954
Present 87 50,9 55,2
Gastritis of the Incisura
Absent 53 36,8 30,5
0,4104
Present 109 63,2 69,5
Type of Gastritis
Absence of Gastritis 47 35,1 25,7
0,4484Superficial 67 38,6 42,9
Difuse 48 26,3 31,4
Intensity of Gastritis
Absence of Gastritis 47 35,1 25,7
0,4434mild 51 29,8 32,4
Moderate or severe 64 35,1 41,9
Metaplasia
Absent 143 91,2 86,7
0,3893
Present 19 8,8 13,3
Hiperplasia
Absent 106 66,7 64,8
0,8084
Present 56 33,3 35,2
1.  Probability to have or no Gastritis, as it doesn’t show 
“postprandial fullness”.
2.  Probability to have or no Gastritis, as it shows 
“postprandial fullness”.
3. Fisher’s exact test. 4. X2 test.
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Table 5. Relation between “nausea” and the presence of gastritis on the histopathological exam.
Characteristics of gastritis Total
“nausea”
p-value
Absent (N=67) (%1) Present (N=95) (%2)
Gastritis
Absent 47 23,9 32,6
0,2274
Present 115 76,1 67,4
Gastritis of the Antrum:
Absent 47 23,9 32,6
0,2274
Present 115 76,1 67,4
Gastritis of the Body
Absent 75 41,8 49,5
0,3344
Present 87 58,2 50,5
Gastritis of the Incisura
Absent 53 28,4 35,8
0,3214
Present 109 71,6 64,2
Type of Gastritis
Absence of Gastritis 47 23,9 32,6
0,4644Superficial 67 43,3 40,0
Difuse 48 32,8 37,4
Intensity of Gastritis
Absence of Gastritis 47 23,9 32,6
0,0594mild 51 41,8 24,2
Moderate or severe 64 34,3 43,2
Metaplasia
Absent 143 89,6 87,4
0,6713
Present 19 10,4 12,6
Hiperplasia
Absent 106 61,2 68,4
0,3414
Present 56 38,8 31,6
1.  Probability to have or no Gastritis, as it doesn’t show 
“nausea”.
2.  Probability to have or no Gastritis, as it shows “nausea”.
3. Fisher’s exact test. 4. X2 test.
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Table 6. Relation between “vomiting” and the presence of gastritis on the histopathological exam.
Characteristics of gastritis Total
“Vomiting”
p-value
Absent (N=126) (%1) Present (N=36) (%2)
Gastritis
Absent 47 28,6 30,6
0,8174
Present 115 71,4 69,4
Gastritis of the Antrum:
Absent 47 28,6 30,6
0,8174
Present 115 71,4 69,4
Gastritis of the Body
Absent 75 46,8 44,4
0,8014
Present 87 53,2 55,6
Gastritis of the Incisura
Absent 53 31,7 36,1
0,6234
Present 109 68,3 63,9
Type of Gastritis
Absence of Gastritis 47 28,6 30,5
0,9424Superficial 67 42,0 39,0
Difuse 48 29,4 30,5
Intensity of Gastritis
Absence of Gastritis 47 28,5 30,6
0,6704mild 51 30,2 36,1
Moderate or severe 64 41,3 33,3
Metaplasia
Absent 143 89,7 83,3
0,2963
Present 19 10,3 16,7
Hiperplasia
Absent 106 65,1 66,7
0,8604
Present 56 34,9 33,3
1.  Probability to have or no Gastritis, as it doesn’t show 
“vomiting”.
2.  Probability to have or no Gastritis, as it shows “vomiting”.
3. Fisher’s exact test. 4. X2 test.
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Table 7. Relation between “bleeding” and the presence of gastritis on the histopathological exam.
Characteristics of gastritis Total
“bleeding”
p-value
Absent (N=153) (%1) Present (N=9) (%2)
Gastritis
Absent 47 29,4 22,2
1,0004
Present 115 70,6 77,8
Gastritis of the Antrum:
Absent 47 29,4 22,2
1,0004
Present 115 70,6 77,8
Gastritis of the Body
Absent 75 47,7 22,2
0,1784
Present 87 52,3 77,8
Gastritis of the Incisura
Absent 53 33,3 22,2
0,7194
Present 109 66,7 77,8
Type of Gastritis
Absence of Gastritis 47 29,4 22,2
1,0004Superficial 67 41,2 44,4
Difuse 48 29,4 33,3
Intensity of Gastritis
Absence of Gastritis 47 29,4 22,2
1,0004mild 51 31,4 33,3
Moderate or severe 64 39,2 44,4
Metaplasia
Absent 143 88,2 88,9
1,0003
Present 19 11,8 11,1
Hiperplasia
Absent 106 64,7 77,8
0,7204
Present 56 35,3 22,2
1.  Probability to have or no Gastritis, as it doesn’t show 
“bleeding”.
2.  Probability to have or no Gastritis, as it shows “bleeding”.
3. Fisher’s exact test. 4. X2 test.
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his difference was significantly different (p=0,043). 
For others signs or symptoms the odds not differ 
significantly. 
Discussion
All 162 patients in the study underwent biopsy with 
histopathology. The diagnosis of gastritis was pre-
sent in 70.9 % of cases, these numbers are very clo-
se to the prevalence of H. pylori, allowing formulate 
the theory that H. pylori is involved in the pathoge-
nesis of gastric inflammation in the present study, 
corroborating data from literature [3]. The place of 
occurrence in all patients with gastritis was the gas-
tric antrum and in 75.6 % of cases also occurred in 
the body. This gastritis was mostly superficial and 
the type mild to moderate intensity. An important 
finding was the presence of intestinal metaplasia in 
19 individuals (11.7%) and almost all had H.pylori. 
An individual had mild dysplasia. These findings, si-
milar to those described in the literature, supports 
the idea that in childhood is the trigger of events 
that will culminate with the appearance of intestinal 
type gastric adenocarcinoma [9-12]. Not forgetting 
that other factors such as heredity, diet (excessive 
salt consumption, poor diet in fresh fruits and vege-
tables) and smoking, contribute substantially to the 
development of gastric atrophy, and consequently 
an increased risk for stomach cancer. In the present 
study only 35% of subjects had follicular lymphoid 
hyperplasia, which contradicts the one found in the 
literature in which the follicular lymphoid hyperpla-
sia is found in 100% of patients with Helicobacter 
pylori [13].
It has been reported that most children and ado-
lescents with H. pylori infection manifested chronic 
active gastritis without predominance of anatomical 
site – antrum or body gastric [14]. Morphological 
changes accompanying H. pylori infection in dys-
pepsia is important in the follow-up and treatment 
of patients. Inflammation and intestinal metaplasia 
increase with increasing Hp intensity in dyspeptic 
patients [15]. The Helicobacter pylori infection result 
in neutrophil activation and chronic gastritis and it 
has a role in the development of intestinal metapla-
sia. The greater the intensity of Helicobacter pylori 
infection, the greater the degrees of neutrophil ac-
tivation, chronic gastritis and intestinal metaplasia 
[16].
The prevalence of H. pylori infection is high among 
children with dyspepsia and is associated with mo-
derate/severe degrees of gastric inflammation [17]. 
Dyspeptic symptoms are frequent in children and its 
association with H. pylori infection is more evident 
than with recurrent abdominal pain [18]. This stu-
dy revealed a probability of 81% of patients with 
H. pylori infection presenting epigastric pain. This 
relationship was statistically significant allowing 
the question: Would the H. pylori infection asso-
ciated with functional dyspepsia? Several studies 
with adults have found no relationship of Hp with 
functional dyspepsia [19-24]. Also Kalach et al. [25] 
in a study of children observed no relationship of 
functional dyspepsia with H. pylori. Unlike, Shmuely 
et al. [26], found a quite evidence of this association. 
It is notable that H. pylori eradication therapy has 
a small but statistically significant effect in H. pylori 
positive non-ulcer dyspepsia [27-31]. When H. pylori 
infection is studied in children and adolescents there 
is a strong correlation with gastrointestinal symp-
toms [18, 32, 33].
Rivera et al [34], analyzed 264 children and ado-
lescents from three months to 17 years old with 
dyspeptic complaints all from Costa Rica, deter-
mining the prevalence of H. pylori by culture and 
histopathology of the gastric mucosa. Ninety-six 
(36.3%) of the children had some degree of gas-
tritis, and in 73 (76%) of them were identified Hp. 
Concluded that these data confirm the importance 
of investigating Helicobacter pylori in children and 
adolescents with gastric discomfort, especially in 
developing countries.
Bala and Czerwionka-Szaflarska [35], investiga-
ting chronic abdominal pain, in Poland, selected 
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910 children and adolescents with chronic gastri-
tis and Helicobacter pylori positive. Concluded that 
chronic gastritis associated with Helicobacter pylori 
in children and adolescents with chronic abdominal 
pain, occurred in 25% of patients, i.e. a quarter of 
the population studied. The authors suggested that 
abdominal pain should be considered during diag-
nostic investigation as relevant clinical data.
Unlike, Turkan et al. [36] concluded that there 
may be an inverse relation between severity of 
symptoms and level of H. pylori induced gastric 
inflammation in patients with functional dyspep-
sia, despite the small numbers of the study po-
pulation.
This study also noted a correlation between the 
presence of epigastric pain and gastritis of the 
antrum and incisura angularis with extension of 
this correlation to the type of superficial gastritis 
of moderate intensity, especially when related to 
H. pylori infection. Patients with intestinal meta-
plasia and lymphoid follicular hyperplasia showed 
no correlation with symptoms, demonstrating that 
cellular changes in gastric mucosa have no clini-
cal significance. Mysorekar et al. [37], verifying 
histopathological changes of antral mucosa in 
355 adult patients in India, found a prevalence of 
61.4% for Hp, with an association of this patho-
gen with antral severe chronic active gastritis, pre-
sence of lymphoid follicles, intestinal metaplasia 
and dysplasia.
A considerable number of studies reported that 
eradication of the Hp halts the progression of pre-
neoplastic lesions. Gastric atrophy in the corpus 
could regress after eradicating H. pylori; however, 
this result was not seen for gastric atrophy of the 
antrum or for IM of the corpus and antrum. The de-
velopment of IM in the stomach is not reversible by 
H. pylori eradication and possibly represents a point 
of no return [38-43]. There is consistent evidence 
that incidence of chronic atrophic gastritis is very 
low in the absence of H. pylori infection [44]. This 
study was not detected chronic atrophic gastritis, 
which suggests that the presence of these lesions 
occurs at an older age. Moreover, it is possible that 
H. pylori eradication at this stage, an initial step of 
life, delaying the appearance of premalignant le-
sions.
Some limitations of this study should be mentio-
ned. First, the number of individuals included could 
affect the quality of the analysis (n = 162). Second, 
the absence of asymptomatic individuals as a con-
trol could affect the results. Although, the control 
considered has been individuals of the sampled 
without gastritis.
In conclusion, this study showed a very consistent 
correlation between epigastric pain and moderate 
to severe superficial gastritis, most often associa-
ted with Hp infection. In contrast, no correlation 
between epigastric pain and intestinal metaplasia 
was observed, the same having been an occasional 
histopathological finding. On the other hand, gastri-
tis of the antrum and angular notch revealed a sta-
tistically significant correlation with regurgitation. 
Gastritis in histopathology was not associated with 
postprandial fullness, nausea, vomiting or gastroin-
testinal bleeding. Other evidence from randomized 
studies, with extended sample will be needed to 
confirm the findings
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